Enterobacter taylorae, a new opportunistic pathogen: Report of four cases

E. M. Rubinstien; P. Klevjer-Anderson; C. A. Smith; M. T. Drouin; J. E. Patterson

doi:10.1128/jcm.31.2.249-254.1993

Enterobacter taylorae, a new opportunistic pathogen: Report of four cases

E. M. Rubinstien, P. Klevjer-Anderson, C. A. Smith, M. T. Drouin, J. E. Patterson

Medicine

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

Severe nosocomial infections due to Enterobacter taylorae (formerly known as CDC Enteric Group 19) are described in four patients. Unlike most members of the Enterobacter genus, the isolates were not susceptible to penicillins or cephalosporins. Restriction endonuclease analysis of E. taylorae DNA obtained from three patients identified two distinct strains. One strain was found in two patients, suggesting a common source which we were not able to identify. We postulate that in patients harboring E. taylorae, the combination of cephalosporin therapy and instrumentation enables this organism to become an opportunistic pathogen.

Original language	English (US)
Pages (from-to)	249-254
Number of pages	6
Journal	Journal of clinical microbiology
Volume	31
Issue number	2
DOIs	https://doi.org/10.1128/jcm.31.2.249-254.1993
State	Published - 1993

ASJC Scopus subject areas

Microbiology (medical)

Access to Document

10.1128/jcm.31.2.249-254.1993

Fingerprint Dive into the research topics of 'Enterobacter taylorae, a new opportunistic pathogen: Report of four cases'. Together they form a unique fingerprint.

Cite this

@article{01d25dde8cab400fa86a835f5df2f2db,

title = "Enterobacter taylorae, a new opportunistic pathogen: Report of four cases",

abstract = "Severe nosocomial infections due to Enterobacter taylorae (formerly known as CDC Enteric Group 19) are described in four patients. Unlike most members of the Enterobacter genus, the isolates were not susceptible to penicillins or cephalosporins. Restriction endonuclease analysis of E. taylorae DNA obtained from three patients identified two distinct strains. One strain was found in two patients, suggesting a common source which we were not able to identify. We postulate that in patients harboring E. taylorae, the combination of cephalosporin therapy and instrumentation enables this organism to become an opportunistic pathogen.",

author = "Rubinstien, {E. M.} and P. Klevjer-Anderson and Smith, {C. A.} and Drouin, {M. T.} and Patterson, {J. E.}",

year = "1993",

doi = "10.1128/jcm.31.2.249-254.1993",

language = "English (US)",

volume = "31",

pages = "249--254",

journal = "Journal of Clinical Microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "2",

}

TY - JOUR

T1 - Enterobacter taylorae, a new opportunistic pathogen

T2 - Report of four cases

AU - Rubinstien, E. M.

AU - Klevjer-Anderson, P.

AU - Smith, C. A.

AU - Drouin, M. T.

AU - Patterson, J. E.

PY - 1993

Y1 - 1993

N2 - Severe nosocomial infections due to Enterobacter taylorae (formerly known as CDC Enteric Group 19) are described in four patients. Unlike most members of the Enterobacter genus, the isolates were not susceptible to penicillins or cephalosporins. Restriction endonuclease analysis of E. taylorae DNA obtained from three patients identified two distinct strains. One strain was found in two patients, suggesting a common source which we were not able to identify. We postulate that in patients harboring E. taylorae, the combination of cephalosporin therapy and instrumentation enables this organism to become an opportunistic pathogen.

AB - Severe nosocomial infections due to Enterobacter taylorae (formerly known as CDC Enteric Group 19) are described in four patients. Unlike most members of the Enterobacter genus, the isolates were not susceptible to penicillins or cephalosporins. Restriction endonuclease analysis of E. taylorae DNA obtained from three patients identified two distinct strains. One strain was found in two patients, suggesting a common source which we were not able to identify. We postulate that in patients harboring E. taylorae, the combination of cephalosporin therapy and instrumentation enables this organism to become an opportunistic pathogen.

UR - http://www.scopus.com/inward/record.url?scp=0027498476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027498476&partnerID=8YFLogxK

U2 - 10.1128/jcm.31.2.249-254.1993

DO - 10.1128/jcm.31.2.249-254.1993

M3 - Article

C2 - 8381808

AN - SCOPUS:0027498476

VL - 31

SP - 249

EP - 254

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 2

ER -